MTOR and acute lymphoblastic leukemia: This reinforces the notion that the PI3K-AKT-mTOR pathway is involved in the oncogenic signalling induced by NRF2 in T-ALL, independently of the mechanism responsible for PI3K-AKT-mTOR activation.